Reference Group Choice and Antibiotic Resistance Outcomes

Kaye, Keith S.; Engemann, John J.; Mozaffari, Essy; Carmeli, Yehuda

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Reference Group Choice and Antibiotic Resistance Outcomes

Published Date:

Jun 2004

Source:

Emerg Infect Dis. 10(6):1125-1128.

[PDF-71.45 KB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

Kaye, Keith S. ; Engemann, John J. ; Mozaffari, Essy ; Carmeli, Yehuda ;

Description:

Two types of cohort studies examining patients infected with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) were contrasted, using different reference groups. Cases were compared to uninfected patients and patients infected with the corresponding, susceptible organism. VRE and MRSA were associated with adverse outcomes. The effect was greater when uninfected control patients were used.

Subject:

[+]

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

Supporting Files:

	02-0665.nxml	text/plain
	license.txt	text/plain

No Related Documents.

You May Also Like:

Evaluation and research on antimicrobial stewardship’s Effect on Clostridium difficile (ERASE C. difficile) Project

Corporate Authors:

Boston University. School of Public Health.. Montefiore Medical Center.. Greater New York Hospital Association/United Hospital Fund.. United States, Agency for Healthcare Research and Quality.. Centers for Disease Control and Prevention (U.S.).

Published Date:

September 2012

Series:

AHRQ publication ; no. 1-0082-EF

File Type:

[PDF - 1.53 MB]
Economic impact of antimicrobial resistance.

Personal Author:

McGowan, J. E.

Published Date:

2001 Mar-Apr

Source:

Emerg Infect Dis. 7(2):286-292.

Description:

One reason antimicrobial-drug resistance is of concern is its economic impact on physicians, patients, health-care administrators, pharmaceutical producers, and the public. Measurement of cost and economic impact of programs to minimize antimicrobial...

File Type:

[PDF - 66.32 KB]
Antimicrobial therapies for Q fever

Personal Author:

Kersh, Gilbert J.

Published Date:

Sep 27 2013

Source:

Expert Rev Anti Infect Ther. 11(11):1207-1214.

Description:

Q fever is caused by the bacterium Coxiella burnetii and has both acute and chronic forms. The acute disease is a febrile illness often with headache and myalgia that can be self-limiting, whereas the chronic disease typically presents as endocarditi...

File Type:

[PDF - 163.49 KB]
Antimicrobial Resistance in Streptococcus pneumoniae, Taiwan

Personal Author:

Hsueh, Po-Ren; Luh, Kwen-Tay;

Published Date:

Dec 2002

Source:

Emerg Infect Dis. 8(12):1487-1491.

Description:

Taiwan has one of the highest levels of antibiotic-resistant pneumococcus in the world. Pneumococcal isolates not susceptible to penicillin first appeared in Taiwan in 1986; in 1995 an increase in the prevalence of nonsusceptibility to penicillins, e...

File Type:

[PDF - 214.90 KB]
Maintaining Fluoroquinolone Class Efficacy: Review of Influencing Factors

Personal Author:

Scheld, W. Michael

Published Date:

Jan 2003

Source:

Emerg Infect Dis. 9(1):1-9.

Description:

Previous experience with antimicrobial resistance has emphasized the importance of appropriate stewardship of these pharmacotherapeutic agents. The introduction of fluoroquinolones provided potent new drugs directed primarily against gram-negative pa...

File Type:

[PDF - 224.38 KB]